Express Scripts Holding Co. (ESRX) |
|
|
|
Express Scripts Holding Co. Income Statement Quarterly
ESRX
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2018) III. Quarter |
(Jun 30 2018) II. Quarter |
(Mar 31 2018) I. Quarter |
(Dec 31 2017) IV. Quarter |
(Sep 30 2017) III. Quarter |
Total Revenue |
25,563.20 |
25,641.80 |
24,769.40 |
25,378.80 |
24,683.40 |
Cost of Revenue |
23,211.80 |
23,437.60 |
22,890.00 |
22,888.30 |
22,445.70 |
Gross
Profit |
2,351.40 |
2,204.20 |
1,879.40 |
2,490.50 |
2,237.70 |
Selling, Administration, Marketing |
862.80 |
892.00 |
917.80 |
908.10 |
759.30 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Restructuring |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
0.00 |
- |
0.00 |
- |
- |
Unusual Income/ -Expense |
- |
- |
- |
- |
- |
Total operating costs including COS |
24,074.60 |
24,329.60 |
23,807.80 |
23,796.40 |
23,205.00 |
Operating income/-loss
|
1,488.60 |
1,312.20 |
961.60 |
1,582.40 |
1,478.40 |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Sale of Business |
- |
- |
- |
- |
- |
Sale of Assets |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
138.00 |
142.50 |
142.00 |
153.80 |
134.10 |
Total costs & expenses |
24,212.60 |
24,472.10 |
23,949.80 |
23,950.20 |
23,339.10 |
Income /-loss before income taxes |
1,350.60 |
1,169.70 |
819.60 |
1,428.60 |
1,344.30 |
Income taxes expenses/-benefit |
276.80 |
290.30 |
193.70 |
-902.30 |
499.30 |
Income after income taxes |
1,073.80 |
879.40 |
625.90 |
2,330.90 |
845.00 |
Net income/-loss
of other equity |
- |
0.00 |
0.00 |
0.00 |
- |
Income/-loss
from cont. Ops. |
1,073.80 |
879.40 |
625.90 |
2,330.90 |
845.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
1,073.80 |
879.40 |
625.90 |
2,330.90 |
845.00 |
Noncontrolling interests |
2.20 |
2.10 |
2.70 |
3.30 |
3.30 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
1,071.60 |
877.30 |
623.20 |
2,327.60 |
841.70 |
EBIT |
1,350.60 |
1,169.70 |
819.60 |
1,428.60 |
1,344.30 |
EBITD |
1,848.30 |
1,673.40 |
1,318.40 |
1,886.40 |
1,793.70 |
EBITDA |
1,848.30 |
1,673.40 |
1,318.40 |
1,886.40 |
1,793.70 |
Per
Share (GAAP Quarterly, in $) |
(Sep 30 2018) III. Quarter |
(Jun 30 2018) II. Quarter |
(Mar 31 2018) I. Quarter |
(Dec 31 2017) IV. Quarter |
(Sep 30 2017) III. Quarter |
Basic EPS (excl. extra
items) |
1.90 |
1.56 |
1.11 |
4.12 |
1.47 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
1.90 |
1.56 |
1.11 |
4.12 |
1.47 |
Basic shares outstanding (Mill.
of Units) |
562.90 |
561.90 |
562.80 |
564.70 |
571.80 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
1.89 |
1.55 |
1.10 |
4.10 |
1.46 |
Diluted average shares (Mill.
of Units) |
567.90 |
565.50 |
567.10 |
568.20 |
574.70 |
Dividend per share |
- |
- |
- |
- |
- |
|
|